These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27735035)

  • 1. Low expression of miR-409-3p is a prognostic marker for breast cancer.
    Cao GH; Sun XL; Wu F; Chen WF; Li JQ; Hu WC
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3825-3829. PubMed ID: 27735035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of miR-302c-3p as prognostic biomarkers in glioma patients.
    Zheng GD; Wang YU; Zhu XD
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1521-5. PubMed ID: 27160124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B; Liu C; Zhang QM; Ni M
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
    Fang C; Wang FB; Li Y; Zeng XT
    Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of MiR-148b-3p in Lung Adenocarcinoma and Its Correlation with Prognosis].
    Huang Z; Li S; Ma Y; Wu N; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):306-311. PubMed ID: 31109440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of miR-655-3p predicts worse clinical outcome in patients suffering from hepatocellular carcinoma.
    Zhao XQ; Liang B; Jiang K; Zhang HY
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):748-752. PubMed ID: 28272708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
    Song CG; Wu XY; Wang C; Fu FM; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
    Zhang P; Fan C; Du J; Mo X; Zhao Q
    Int J Exp Pathol; 2018 Aug; 99(4):199-205. PubMed ID: 30175411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.